A Review of Prospective Studies Regarding Percutaneous Peripheral Nerve Stimulation Treatment in the Management of Chronic Pain

Overview

Journal Pain Manag

Specialty Psychiatry

Date 2024 Jun 28

PMID 38939963

Authors

Scott G Pritzlaff

Usman Latif

Joshua M Rosenow

John Chae

Richard D Wilson

William J Huffman

Nathan D Crosby

Joseph W Boggs

Affiliations

Soon will be listed here.

Abstract

Conventionally, peripheral nerve stimulation (PNS) for treatment of chronic pain has involved a two-stage process: a short-term (e.g., 7 days) trial and, if significant pain relief is achieved, a permanent PNS system is implanted. A percutaneous PNS treatment is now available where a coiled lead may be implanted for up to 60 days with the goal of producing sustained relief. In the present review, published prospective trials using percutaneous PNS treatment were identified and synthesized. The collected evidence indicates that percutaneous PNS treatment for up to 60 days provides durable clinically significant improvements in pain and pain interference. Similar efficacy across diverse targets and etiologies supports the broad applicability for use within the chronic pain population using this nonopioid technology.

References

Bartsch T, Goadsby P . Central mechanisms of peripheral nerve stimulation in headache disorders. Prog Neurol Surg. 2011; 24:16-26. DOI: 10.1159/000323008. View

Chae J, Wilson R, Bennett M, Lechman T, Stager K . Single-lead percutaneous peripheral nerve stimulation for the treatment of hemiplegic shoulder pain: a case series. Pain Pract. 2012; 13(1):59-67. PMC: 3387352. DOI: 10.1111/j.1533-2500.2012.00541.x. View

Gaskin D, Richard P . The economic costs of pain in the United States. J Pain. 2012; 13(8):715-24. DOI: 10.1016/j.jpain.2012.03.009. View

Wilson R, Harris M, Gunzler D, Bennett M, Chae J . Percutaneous peripheral nerve stimulation for chronic pain in subacromial impingement syndrome: a case series. Neuromodulation. 2014; 17(8):771-6. PMC: 4128958. DOI: 10.1111/ner.12152. View

Deer T, Gilmore C, Desai M, Li S, DePalma M, Hopkins T . Percutaneous Peripheral Nerve Stimulation of the Medial Branch Nerves for the Treatment of Chronic Axial Back Pain in Patients After Radiofrequency Ablation. Pain Med. 2021; 22(3):548-560. PMC: 7971467. DOI: 10.1093/pm/pnaa432. View

Pingree M, Hurdle M, Spinner D, Valimahomed A, Crosby N, Boggs J . Real-world evidence of sustained improvement following 60-day peripheral nerve stimulation treatment for pain: a cross-sectional follow-up survey. Pain Manag. 2022; 12(5):611-621. DOI: 10.2217/pmt-2022-0005. View

Gilmore C, Kapural L, McGee M, Boggs J . Percutaneous Peripheral Nerve Stimulation for Chronic Low Back Pain: Prospective Case Series With 1 Year of Sustained Relief Following Short-Term Implant. Pain Pract. 2019; 20(3):310-320. PMC: 7079182. DOI: 10.1111/papr.12856. View

Xu J, Sun Z, Wu J, Rana M, Garza J, Zhu A . Peripheral Nerve Stimulation in Pain Management: A Systematic Review. Pain Physician. 2021; 24(2):E131-E152. PMC: 8897810. View

Gilmore C, Kapural L, McGee M, Boggs J . Percutaneous Peripheral Nerve Stimulation (PNS) for the Treatment of Chronic Low Back Pain Provides Sustained Relief. Neuromodulation. 2018; 22(5):615-620. DOI: 10.1111/ner.12854. View

10.

Pilitsis J, Fahey M, Custozzo A, Chakravarthy K, Capobianco R . Composite Score Is a Better Reflection of Patient Response to Chronic Pain Therapy Compared With Pain Intensity Alone. Neuromodulation. 2020; 24(1):68-75. DOI: 10.1111/ner.13212. View

11.

King N, Fraser V . Untreated pain, narcotics regulation, and global health ideologies. PLoS Med. 2013; 10(4):e1001411. PMC: 3614505. DOI: 10.1371/journal.pmed.1001411. View

12.

Jensen M, Turner J, Romano J, Fisher L . Comparative reliability and validity of chronic pain intensity measures. Pain. 1999; 83(2):157-62. DOI: 10.1016/s0304-3959(99)00101-3. View

13.

Latremoliere A, Woolf C . Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009; 10(9):895-926. PMC: 2750819. DOI: 10.1016/j.jpain.2009.06.012. View

14.

Sampson M, Barrowman N, Moher D, Klassen T, Pham B, Platt R . Should meta-analysts search Embase in addition to Medline?. J Clin Epidemiol. 2003; 56(10):943-55. DOI: 10.1016/s0895-4356(03)00110-0. View

15.

Horlocker T, Wedel D, Benzon H, Brown D, Enneking F, Heit J . Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003; 28(3):172-97. DOI: 10.1053/rapm.2003.50046. View

16.

Gabriel R, Ilfeld B . Peripheral nerve blocks for postoperative analgesia: From traditional unencapsulated local anesthetic to liposomes, cryoneurolysis and peripheral nerve stimulation. Best Pract Res Clin Anaesthesiol. 2019; 33(3):293-302. DOI: 10.1016/j.bpa.2019.06.002. View

17.

Radbruch L, Loick G, Kiencke P, Lindena G, Sabatowski R, Grond S . Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage. 1999; 18(3):180-7. DOI: 10.1016/s0885-3924(99)00064-0. View

18.

Char S, Jin M, Tieppo Francio V, Hussain N, Wang E, Morsi M . Implantable Peripheral Nerve Stimulation for Peripheral Neuropathic Pain: A Systematic Review of Prospective Studies. Biomedicines. 2022; 10(10). PMC: 9599770. DOI: 10.3390/biomedicines10102606. View

19.

Smith T, Hillner B . The Cost of Pain. JAMA Netw Open. 2019; 2(4):e191532. DOI: 10.1001/jamanetworkopen.2019.1532. View

20.

Deer T, Naidu R, Strand N, Sparks D, Abd-Elsayed A, Kalia H . A review of the bioelectronic implications of stimulation of the peripheral nervous system for chronic pain conditions. Bioelectron Med. 2020; 6:9. PMC: 7181529. DOI: 10.1186/s42234-020-00045-5. View